Recombinant multi-species ARHGDIB protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ARHGDIB protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Members of the Rho (or ARH) protein family (see MIM 165390) and other Ras-related small GTP-binding proteins (see MIM 179520) are involved in diverse cellular events, including cell signaling, proliferation, cytoskeletal organization, and secretion. The GTP-binding proteins are active only in the GTP-bound state. At least 3 classes of proteins tightly regulate cycling between the GTP-bound and GDP-bound states: GTPase-activating proteins (GAPs), guanine nucleotide-releasing factors (GRFs), and GDP-dissociation inhibitors (GDIs). The GDIs, including ARHGDIB, decrease the rate of GDP dissociation from Ras-like GTPases (summary by Scherle et al., 1993 [PubMed 8356058]).[supplied by OMIM, Dec 2010]
The Alternative Names of target: ARHGDIB,Arhgdib,D4,GDIA2,GDID4,Gdid4,LYGDI,Ly-GDI,RAP1GN1,Rho GDI 2,Rho GDP-dissociation inhibitor 2,Rho-GDI beta,RhoGDI2

Target products collectionGo to ARHGDIB products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP8660-Ag-1/ GM-Tg-hg-IP8660-Ag-2 Human ARHGDIB protein Human
GM-Tg-rg-IP8660-Ag-1/ GM-Tg-rg-IP8660-Ag-2 Rat ARHGDIB protein Rat
GM-Tg-mg-IP8660-Ag-1/ GM-Tg-mg-IP8660-Ag-2 Mouse ARHGDIB protein Mouse
GM-Tg-cynog-IP8660-Ag-1/ GM-Tg-cynog-IP8660-Ag-2 Cynomolgus/Rhesus macaque ARHGDIB protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP8660-Ag-1/ GM-Tg-felg-IP8660-Ag-2 Feline ARHGDIB protein Feline
GM-Tg-cang-IP8660-Ag-1/ GM-Tg-cang-IP8660-Ag-2 Canine ARHGDIB protein Canine
GM-Tg-bovg-IP8660-Ag-1/ GM-Tg-bovg-IP8660-Ag-2 Bovine ARHGDIB protein Bovine
GM-Tg-equg-IP8660-Ag-1/ GM-Tg-equg-IP8660-Ag-2 Equine ARHGDIB protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP8660-Ag-1/ GM-Tg-hg-IP8660-Ag-2; GM-Tg-rg-IP8660-Ag-1/ GM-Tg-rg-IP8660-Ag-2;
GM-Tg-mg-IP8660-Ag-1/ GM-Tg-mg-IP8660-Ag-2; GM-Tg-cynog-IP8660-Ag-1/ GM-Tg-cynog-IP8660-Ag-2;
GM-Tg-felg-IP8660-Ag-1/ GM-Tg-felg-IP8660-Ag-2; GM-Tg-cang-IP8660-Ag-1/ GM-Tg-cang-IP8660-Ag-2;
GM-Tg-bovg-IP8660-Ag-1/ GM-Tg-bovg-IP8660-Ag-2; GM-Tg-equg-IP8660-Ag-1/ GM-Tg-equg-IP8660-Ag-2
Products Name ARHGDIB protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ARHGDIB
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ARHGDIB protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.